Humana Inc. (NYSE:HUM) Shares Sold by Apollon Wealth Management LLC

Apollon Wealth Management LLC trimmed its position in Humana Inc. (NYSE:HUM) by 8.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,815 shares of the insurance provider’s stock after selling 259 shares during the period. Apollon Wealth Management LLC’s holdings in Humana were worth $892,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. CarsonAllaria Wealth Management Ltd. lifted its stake in shares of Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after buying an additional 39 shares during the period. Creative Financial Designs Inc. ADV lifted its stake in shares of Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after buying an additional 61 shares during the period. Atwood & Palmer Inc. acquired a new stake in shares of Humana during the third quarter worth $29,000. Hantz Financial Services Inc. acquired a new stake in shares of Humana during the second quarter worth $35,000. Finally, Family Firm Inc. acquired a new stake in shares of Humana during the second quarter worth $37,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on HUM shares. KeyCorp started coverage on shares of Humana in a research note on Friday, October 11th. They set a “sector weight” rating for the company. Stephens restated an “equal weight” rating and set a $250.00 target price on shares of Humana in a research report on Wednesday, October 9th. JPMorgan Chase & Co. boosted their target price on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a research report on Wednesday, August 21st. Royal Bank of Canada decreased their target price on shares of Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Finally, Wells Fargo & Company decreased their target price on shares of Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. Twenty analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, Humana has an average rating of “Hold” and an average target price of $315.86.

Humana Stock Down 2.6 %

HUM stock opened at $275.67 on Friday. The stock has a market capitalization of $33.19 billion, a P/E ratio of 24.42, a P/E/G ratio of 2.29 and a beta of 0.52. The firm has a 50-day simple moving average of $283.00 and a 200-day simple moving average of $331.80. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $527.18.

Humana (NYSE:HUM) last released its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Equities analysts forecast that Humana Inc. will post 15.83 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.28%. Humana’s dividend payout ratio is presently 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.